Gisela Weiz

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Molecular Docking

Hydrogen Peroxide

Hepatitis C Virus

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Applied microbiology and biotechnology

Biotechnology and applied biochemistry

Current pharmaceutical design

This page only lists publications with an associated author ORCID identifier.

Publications

Caecilia H C Sukowati, Gisela Weiz, Witri W Lestari, Claudio Tiribelli
Glycosylated-drug Delivery as Targeted Therapy for Hepatocellular Carcinoma: Are We There Yet? Current pharmaceutical design (2023)
Gisela Weiz, Maria I Molejon, Mariana Malvicini, Caecilia H C Sukowati, Claudio Tiribelli, Guillermo Mazzolini, Javier D Breccia
Glycosylated 4-methylumbelliferone as a targeted therapy for hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver (2021)
Gisela Weiz, Laura S Mazzaferro, Michael Kotik, Bárbara D Neher, Petr Halada, Vladimir Kren, Javier D Breccia
The flavonoid degrading fungus Acremonium sp. DSM 24697 produces two diglycosidases with different specificities. Applied microbiology and biotechnology 103 (23-24) (2019)
Laura S Mazzaferro, Gisela Weiz, Lucas Braun, Michael Kotik, Helena Pelantová, Vladimir Kren, Javier D Breccia
Enzyme-mediated transglycosylation of rutinose (6-O-α-l-rhamnosyl-d-glucose) to phenolic compounds by a diglycosidase from Acremonium sp. DSM 24697. Biotechnology and applied biochemistry 66 (1) (2018)